October 2015, Vol. 4, No. 5

← Back to Issue

Genetic Counseling in Personalizing Care: A New Department in PMO

Genetic Counseling in Personalizing Care: A New Department in PMO

Letter to Our Readers

Dear Colleague,

I am pleased to announce a new department in PMO, Genetic Counseling. In each issue, PMO editorial board member Cristi Radford, MS, CGC, of the Moffitt Cancer Center will contribute an impactful article. In this issue, you will read about BRCA1/2 testing for any patient with pancreatic adenocarcinoma. If you have an intriguing case to share, I encourage you to submit it to our Editorial Director at Ksiyahian@the-lynx-group.com.

The mission of our journal is to provide a bridge between academic research and practicing clinicians by demonstrating the immediate implications of precision medicine—including advances in molecular sequencing, targeted therapies, and new diagnostic modalities—to the management of patients with cancer, offering oncologists, oncology nurses, payers, researchers, drug developers, policymakers, and all oncology stakeholders the relevant practical information they need to improve cancer outcomes. Improved outcomes lie in the ability to administer effective therapies. Our ability to prescribe effective therapies has more and more become reliant on our understanding of the molecular biology of the tumor microenvironment as well as the genomic and genetic information of the patient.

To this end, this month we offer an intriguing interview with Nazneen Aziz, PhD, of the Phoenix Children’s Hospital revealing how genetic, genomic, and biomarker information is being put to work to improve outcomes for patients. We also present a case study on molecular pathways in non–small cell lung cancer as well as several other relevant articles on the personalized approach to caring for patients with cancer.

As always, thank you for your loyal readership. We hope the addition of the genetic counseling department will be of value to you in your practice.

Sincerely,

Al B. Benson III, MD, FACP, FASCO
Coeditor in Chief
Personalized Medicine in Oncology

Interview with the Innovators - October 14, 2015

Accelerating Genomic Sequencing and Personalized Therapies for Young Patients

The Chan Soon-Shiong Children’s Precision Medicine Institute is a joint venture between Phoenix Children’s Hospital and Patrick Soon-Shiong Dr Patrick Soon-Shiong is the founder of Nantworks, a company largely dedicated to applying genomic and proteomic analysis studies to translate diagnoses and cures more quickly and accurately. Historically, his efforts have [ Read More ]

WCMC - October 16, 2015

Update to Approaches to Therapy in Malignant Melanoma

Current approaches to the treatment and follow-up of patients with malignant melanoma, including those with brain metastases, were reviewed by speakers at the 2015 World Cutaneous Malignancies Congress. Approach to the BRAF-Positive Patient Melanoma is an immunogenic oncogene-driven cancer, said Grant McArthur, MB, BS, PhD, in explaining the rationale for [ Read More ]